We are international
Donate
TEXT SIZE   


Myeloma Minute
December 17, 2015
12.17.15
December 17, 2015
Share the Minute Facebook Tweet!
Clinical Trials
Donate to the IMF
   

 
This week's question: What should we know about FDA approval of Darzalex (daratumumab)?


Multiple Myeloma Bone Study

New ARROW Clinical Trials: Learn How To Participate

New Selinexor STORM Clinical Trials: Learn How To Participate

New Ixazomib Clinical Trials: Learn How To Participate

Join the conversation about myeloma on the Smart Patients Message Board

Upcoming Events

February 14, 2015
Race Toward a Cure with the IMF in the Skechers LA Marathon

Los Angeles, California

February 26 - February 27, 2016
Patient and Family Seminar

Boca Raton, Florida

March 18 - March 19, 2016
Patient and Family Seminar

Seattle, Washington

 

 

 

 

    

x

Three Holiday Presents for Myeloma Patients

With the recent FDA approvals of the myeloma drugs Darzalex (daratumamab), Ninlaro (ixazomib) and Empliciti (elotuzamab), the end of 2015 offered many holiday presents for myeloma patients. But, as IMF Chairman Dr. Brian Durie writes in his blog this week, in the New Year, myeloma doctors will need to figure out how to use these drugs in a clinical setting. To read Dr. Durie’s blog, click HERE.

x

Shop for the IMF!



 

Shop with the leading merchants on the Internet, receive the same price as anyone else visiting their sites, and support the IMF at the same time! Visit popular merchants such as Amazon, Walmart, and others, and a percentage of your purchase goes to support the IMF. Please remember that the IMF receives a donation ONLY IF YOU VISIT THE IMF ONLINE MALL and purchase from the links listed on this page. You may want to bookmark this page to ensure that when you are shopping, your purchases are properly credited. And keep checking back as we add new stores to our Mall. Thanks for your support!

x

Free Best of ASH 2015 Teleconference


 

Now that the American Society of Hematology’s (ASH) 2015 annual meeting has come to a close, attendees are sorting through the breadth of knowledge, research, and educational information shared. To simplify the latest trends in myeloma research, the IMF will present a free teleconference: “The Best of ASH 2015: What Patients & Caregivers Need to Know.” Dr. Brian Durie will host this ninety-minute session on Thursday, January 7, 2016, at 4 PM PT / 7 PM ET. If you tune into the teleconference, you will also have a chance to participate—30 minutes of this teleconference will feature a question and answer session with Dr. Durie. To pre-register for this event today, click HERE.

x

And That's a Wrap: Myeloma Support Group Leaders' Final Thoughts on ASH 2015


 

 

The IMF sent 15 Support Group Leaders (SGLs) from around the country to the largest hematological cancer meeting of the year in Orlando, FL, in early December.  While attending, the SGLs blogged and tweeted the latest news in myeloma research. Now that they have returned to their hometowns, these patient advocates weigh in on ASH topics most important to them: when to treat smoldering multiple myeloma; the newly approved FDA oral agents in individual treatments; MRD-testing; and more. To read these wrap-up blogs, click HERE.

 

 


 

 

 


Join Our Mailing List

 
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF InfoLine: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe
www.myeloma.org

.

 


 related articles